PRESS RELEASE published on 12/20/2023 at 12:45, 2 years 9 months ago MindBio Therapeutics CEO Provides End of Year Video Update on Phase 2 Clinical Trials
PRESS RELEASE published on 11/21/2023 at 14:42, 2 years 10 months ago MindBio Therapeutics Team Members Honoured with Industry Leading Awards
PRESS RELEASE published on 10/31/2023 at 07:30, 2 years 11 months ago MindBio Therapeutics CEO Presents World First Phase 2B Take-Home Microdosing Clinical Trial in Cancer Patients
PRESS RELEASE published on 10/29/2023 at 03:00, 2 years 11 months ago MindBio Therapeutics Begins Dosing MB22001 in World First Phase 2B Microdosing Clinical Trial In Advanced Stage Cancer Patients
PRESS RELEASE published on 10/26/2023 at 14:50, 2 years 11 months ago Mindbio Therapeutics Nominated for Company of the Year in Industry Awards
PRESS RELEASE published on 10/24/2023 at 13:25, 2 years 11 months ago MindBio Therapeutics CEO Provides Video Update on Phase 2a Depression Trial Using MB22001
PRESS RELEASE published on 10/05/2023 at 11:29, 3 years ago Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials
PRESS RELEASE published on 09/14/2023 at 15:45, 3 years ago Mindbio Therapeutics CEO Provides Update on Depression Trial & Novel Discoveries in Psychedelics Research
PRESS RELEASE published on 09/05/2023 at 11:50, 3 years 1 month ago MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research
PRESS RELEASE published on 08/24/2023 at 08:30, 3 years 1 month ago Begins Dosing Mb22001 in Phase 2 Clinical Trial in World First Take-Home Microdosing Study in Patients with Depression
Published on 10/06/2026 at 16:45, 5 hours 54 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 10/06/2026 at 16:30, 6 hours 9 minutes ago Snipp Survey Finds AI is Reshaping the Shopper Journey, with 61.8% of AI Users Having Purchased After an AI Recommendation
Published on 10/06/2026 at 15:45, 6 hours 54 minutes ago Stagwell Launches New Global Media Agency, Stagwell Media
Published on 10/06/2026 at 15:00, 7 hours 39 minutes ago Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
Published on 10/06/2026 at 14:31, 8 hours 8 minutes ago Worksport (Nasdaq: WKSP) Books $2.92M August Orders; Annualized Order Run Rate Reaches $35M
Published on 10/06/2026 at 19:05, 3 hours 34 minutes ago Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
Published on 10/06/2026 at 18:30, 4 hours 9 minutes ago Avolta’s Hudson secures new 20-year duty-free contract at Seattle-Tacoma International
Published on 10/06/2026 at 18:05, 4 hours 34 minutes ago Lepermislibre: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 10/06/2026 at 18:00, 4 hours 39 minutes ago ARVERNE GROUP: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026
Published on 10/06/2026 at 18:00, 4 hours 39 minutes ago ARVERNE GROUP: Total number of shares and voting rights in the share capital as of September 30, 2026
Published on 10/06/2026 at 19:15, 3 hours 24 minutes ago Air Liquide has successfully issued a 2 billion euros multi-tranche bond
Published on 10/06/2026 at 19:15, 3 hours 24 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 2 milliards d’euros
Published on 10/06/2026 at 18:39, 3 hours 59 minutes ago Capital et droits de vote au 30 septembre 2026
Published on 10/06/2026 at 18:39, 3 hours 59 minutes ago Total number of voting rights and shares making up the share capital at September 30, 2026
Published on 10/06/2026 at 18:15, 4 hours 24 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026
